Private Securities Litigation Reform Act

Infosys BPM Launches State-of-the-art Center of AI and Automation in Poland, in Collaboration with IBM

Retrieved on: 
Monday, November 14, 2022

The center will complement Infosys BPM service offerings that are built with a design thinking approach and deep domain expertise in data and AI technologies.

Key Points: 
  • The center will complement Infosys BPM service offerings that are built with a design thinking approach and deep domain expertise in data and AI technologies.
  • The center launch also commemorates the 15th anniversary of Infosys BPM in Poland.
  • The center will showcase AI and automation solutions for business processes, and these solutions, including through automation, help lower costs, enhance productivity, and elevate customer experience.
  • Clients will get hands-on access to various digital solution offerings across the space of data, AI, and hyperautomation, such as IBM CloudPak for Data, IBM Watson Assistant & IBM Watson Discovery, IBM SaferPayments, IBM Blockchain, IBM Sterling Supply Chain, IBM Risk and Fraud Detection software, and Envizi for Sustainability, along with key solutions from Infosys BPM, including Infosys Intelligent Document Processing, Infosys Interaction Analytics, Infosys Multilingual Conversational AI, Infosys Accounts Payable on Cloud, Infosys Cortex, Infosys Material Master Harmonization, and Infosys Data Workbench, among many others.

Infosys BPM Launches State-of-the-art Center of AI and Automation in Poland, in Collaboration with IBM

Retrieved on: 
Monday, November 14, 2022

The center will complement Infosys BPM service offerings that are built with a design thinking approach and deep domain expertise in data and AI technologies.

Key Points: 
  • The center will complement Infosys BPM service offerings that are built with a design thinking approach and deep domain expertise in data and AI technologies.
  • The center launch also commemorates the 15th anniversary of Infosys BPM in Poland.
  • The center will showcase AI and automation solutions for business processes, and these solutions, including through automation, help lower costs, enhance productivity, and elevate customer experience.
  • Clients will get hands-on access to various digital solution offerings across the space of data, AI, and hyperautomation, such as IBM CloudPak for Data, IBM Watson Assistant & IBM Watson Discovery, IBM SaferPayments, IBM Blockchain, IBM Sterling Supply Chain, IBM Risk and Fraud Detection software, and Envizi for Sustainability, along with key solutions from Infosys BPM, including Infosys Intelligent Document Processing, Infosys Interaction Analytics, Infosys Multilingual Conversational AI, Infosys Accounts Payable on Cloud, Infosys Cortex, Infosys Material Master Harmonization, and Infosys Data Workbench, among many others.

Intellia Therapeutics Presents New Interim Data from First-in-Human Study of NTLA-2002 for the Treatment of Hereditary Angioedema (HAE) at the American College of Allergy, Asthma & Immunology 2022 Annual Scientific Meeting

Retrieved on: 
Saturday, November 12, 2022

Importantly, the safety data from all 10 patients are highly encouraging, further supporting NTLA-2002s potential to change the future HAE treatment paradigm.

Key Points: 
  • Importantly, the safety data from all 10 patients are highly encouraging, further supporting NTLA-2002s potential to change the future HAE treatment paradigm.
  • At all three dose levels, NTLA-2002 was generally well-tolerated, and the majority of adverse events were mild in severity.
  • The most frequent adverse events were infusion-related reactions, which were mostly Grade 1 and resolved within one day.
  • Intellia anticipates expanding country and site participation, including U.S. clinical sites, as part of the Phase 2 study.

HUMBL Launches Digital Collectibles Program with Samoa Rugby League Team

Retrieved on: 
Saturday, November 12, 2022

London, England, Nov. 12, 2022 (GLOBE NEWSWIRE) -- HUMBL (OTCQB: HMBL) announced today that it has launched a digital collectibles NFT program with the Rugby League Samoa Alliance.

Key Points: 
  • London, England, Nov. 12, 2022 (GLOBE NEWSWIRE) -- HUMBL (OTCQB: HMBL) announced today that it has launched a digital collectibles NFT program with the Rugby League Samoa Alliance.
  • Samoa national team fans from around the world will now be able to collect digital NFTs of their favorite players in their HUMBL digital wallets.
  • We deeply value this connection with the Rugby League Samoa Alliance, said Brian Foote, CEO of HUMBL.
  • HUMBL is a Web 3 platform that integrates the HUMBL Search Engine, HUMBL Wallet, HUMBL Tickets, HUMBL NFT Gallery and HUMBL Marketplace into digital experiences for customers.

Baozun’s Total Order Value for the 2022 11.11 Shopping Festival Exceeded RMB21.5 Billion

Retrieved on: 
Saturday, November 12, 2022

SHANGHAI, China, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Baozun Inc.(Nasdaq: BZUN and HKEX: 9991) (Baozun or the Company), a leading brand e-commerce solution provider and digital commerce enabler inChina, today announced a record high total order value for the 2022 11.11 Shopping Festival (11.11 Festival).

Key Points: 
  • SHANGHAI, China, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Baozun Inc.(Nasdaq: BZUN and HKEX: 9991) (Baozun or the Company), a leading brand e-commerce solution provider and digital commerce enabler inChina, today announced a record high total order value for the 2022 11.11 Shopping Festival (11.11 Festival).
  • This years 11.11 Festival started at 20:00:00, China time, on October 31, 2022, and continued uninterrupted for 11 days through November 11, 2022.
  • The total order value settled through payment gateways on all of the Companys e-commerce channels for the 2022 11.11 Festival exceeded RMB21.5 billion, an increase of 12.3% compared to the same period in 2021.
  • Statements that are not historical facts, including but not limited to statements about Baozuns beliefs and expectations, are forward-looking statements.

Atlis Motor Vehicles to Hold Live Stream Town Hall on November 15, 2022 at 12:00pm ET / 9:00am PT

Retrieved on: 
Friday, November 11, 2022

Interested participants may register for the event via:

Key Points: 
  • Interested participants may register for the event via:
    Atlis Motor Vehicles is a startup EV ecosystem technology company developing products that will power work.
  • This communication includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995.
  • However, while Atlis may elect to update these forward-looking statements at some point in the future, Atlis specifically disclaims any obligation to do so.
  • These forward-looking statements should not be relied upon as representing Atlis's assessments as of any date subsequent to the date of this communication.

INVESTOR ALERT: Unisys Corporation Investors with Substantial Losses Have Opportunity to Lead the Unisys Class Action Lawsuit - UIS

Retrieved on: 
Saturday, November 12, 2022

Pa.), the Unisys class action lawsuit charges Unisys and certain of its top executives with violations of the Securities Exchange Act of 1934.

Key Points: 
  • Pa.), the Unisys class action lawsuit charges Unisys and certain of its top executives with violations of the Securities Exchange Act of 1934.
  • Lead plaintiff motions for the Unisys class action lawsuit must be filed with the court no later than January 10, 2023.
  • A lead plaintiff acts on behalf of all other class members in directing the Unisys class action lawsuit.
  • An investors ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Unisys class action lawsuit.

Electra Announces Voting Results of its 2022 Annual Meeting of Shareholders

Retrieved on: 
Friday, November 11, 2022

At the Meeting, shareholders also approved an amended and restated Long-Term Incentive Plan (the 2022 LTIP), as described in the Circular.

Key Points: 
  • At the Meeting, shareholders also approved an amended and restated Long-Term Incentive Plan (the 2022 LTIP), as described in the Circular.
  • Shareholders also approved a new Employee Share Purchase Plan for the Company (the ESP Plan).
  • The 2022 LTIP and ESP Plan were conditionally approved by the TSXV on September 29, 2022 and remain subject to final acceptance of the TSXV.
  • The Companys full voting results at the meeting are available on SEDAR.

ProKidney to Participate in Upcoming Investor Conferences

Retrieved on: 
Friday, November 11, 2022

WINSTON-SALEM, N.C., Nov. 11, 2022 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (ProKidney), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced that Dr. Tim Bertram, Chief Executive Officer, will participate in the following upcoming investor conferences:

Key Points: 
  • WINSTON-SALEM, N.C., Nov. 11, 2022 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (ProKidney), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced that Dr. Tim Bertram, Chief Executive Officer, will participate in the following upcoming investor conferences:
    Jefferies London Healthcare Conference: Dr. Bertram will participate in a fireside chat on Wednesday, November 16, 2022, at 12:20 PM GMT (7:20 AM ET).
  • Evercore ISI 5th Annual HEALTHCONx Virtual Conference: Dr. Bertram will participate in a fireside chat on Thursday, December 1, 2022 at 10:05 AM ET.
  • Investors participating in the conferences who are interested in meeting with ProKidney management may request a meeting by contacting their Jefferies or Evercore ISI representative.
  • ProKidney, a pioneer in the treatment of CKD through innovations in cellular therapy, was founded in 2015 after a decade of research.

Horizon Global Announces Receipt of Continued Listing Standard Notice From the NYSE

Retrieved on: 
Friday, November 11, 2022

The Company will notify the NYSE of its intent to cure the stock price deficiency and return to compliance with the continued listing standard.

Key Points: 
  • The Company will notify the NYSE of its intent to cure the stock price deficiency and return to compliance with the continued listing standard.
  • Horizon Global intends to closely monitor its stock price during the cure period and will, if necessary, consider available alternatives to cure the stock price non-compliance.
  • The Company's common stock will continue to be listed and traded on the NYSE during the cure period, subject to the Company's compliance with other NYSE continued listing standards.
  • Horizon Global is home to some of the worlds most recognized brands in the towing and trailering industry, including: Draw-Tite, Reese, Westfalia, BULLDOG, Fulton and Tekonsha.